Skip to main content
. 2021 Sep 3;21:989. doi: 10.1186/s12885-021-08729-0

Fig. 4.

Fig. 4

Circulating miR-1290 is a potential diagnostic biomarker in gastrointestinal tumors. a Serum miR-1290 expression levels in PC patients (n = 46) and healthy controls (n = 50) were analyzed by RT-qPCR. b Serum miR-1290 expression levels in CRC patients (n = 50) and healthy controls (n = 50) were analyzed by RT-qPCR. c serum miR-1290 expression levels in GC patients (n = 50) and healthy controls (n = 50) were analyzed by RT-qPCR. d Circulating miR-1290 yielded AUC value of 0.8857 with 67.4% sensitivity and 90.0% specificity in distinguishing PC patients from healthy controls (p < 0.001). e Circulating miR-1290 yielded AUC value of 0.7852 with 48.0% sensitivity and 90.0% specificity in distinguishing CRC patients from healthy controls (p < 0.001). f Circulating miR-1290 yielded AUC value of 0.6576 with 34.0% sensitivity and 90.0% specificity in distinguishing GC patients from healthy controls (p < 0.001). g Sensitivity and specificity of circulating miR-1290 combined with CA199 were 80.4 and 90.0% with the AUC value of 0.9626 in PC (p < 0.0001). h Sensitivity and specificity of circulating miR-1290 combined with CEA were 58.0 and 90.0% with the AUC value of 0.8348 in CRC (p < 0.0001). i Sensitivity and specificity of circulating miR-1290 combined with CA211 were 38.0 and 90.0% with the AUC value of 0.7788 in PC (p < 0.0001). * p < 0.05, ** p < 0.01